Holen Sie sich die Stockscreener-App
29.06
0.10%
-0.03
Smith Nephew Plc Adr Aktie (SNN) Neueste Nachrichten
FTSE 100 Smith & Nephew (LSE:SN.): Outlook and Dividend - Kalkine Media
A Look at Smith & Nephew PLC (SNN) After 4.3% Gain -- GF Value $30.88 vs Price $29.09 - GuruFocus
Why Is Smith & Nephew (LSE:SN.) Stock Under Scrutiny After Cutting Its Sales Outlook? - Kalkine Media
SMITH & NEPHEW PLC (SN1N.MX) Q2 FY2026 earnings call transcript - Yahoo Finance
Smith & Nephew plc Completes the Pricing of USD 700,000,000 5.750% Notes Due 2036 - marketscreener.com
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets - Zacks Investment Research
A November 4 analyst call will follow Smith & Nephew (SNN)'s Q3 trading report. - Stock Titan
Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal - GlobeNewswire Inc.
Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo. - GlobeNewswire Inc.
A five-year trial found better knee pain relief with a cartilage implant than standard surgery. - Stock Titan
5.150% notes due 2027 are named in Smith & Nephew (NYSE: SNN)'s NYSE removal notice. - Stock Titan
Smith & Nephew PLC's Dividend Analysis - Yahoo Finance
Smith & Nephew stock hits 52-week low at 26.39 USD - Investing.com Nigeria
Smith & Nephew plc Announces Redemption Price of $350,000,000 5.150% Notes Due 2027 - marketscreener.com
837M shares carry votes at Smith & Nephew (SNN). Another 40.3M shares are held in treasury. - Stock Titan
The 5.150% notes due in 2027 will be redeemed by Smith & Nephew (SNN) on October 5. - Stock Titan
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Zacks Investment Research
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Yahoo Finance
AlphaValue/Baader Europe Downgrades Smith & Nephew to Add - marketscreener.com
Smith & Nephew: Estimates reset after guidance cut - marketscreener.com
Smith & Nephew (LSE:SN) Rolls Out EVOS PELVIC This Week: Can It Lift Its Orthopaedic Trauma Game? - Kalkine Media
Smith & Nephew stock faces a Q2 revenue miss - AD HOC NEWS
Smith and Nephew stock falls 0.24 percent ahead of the open - AD HOC NEWS
Smith & Nephew stock trades near its yearly low - AD HOC NEWS
Smith+Nephew Launches the New Evos? Pelvic Plating System - marketscreener.com
One system combines plates, screws and tools for complex pelvic fracture surgery - Stock Titan
Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System - markets.businessinsider.com
Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical case of LANDMARK◊ Total Knee System - Ortho Spine News
This shoulder implant has been used in more than 250,000 procedures. Smith+Nephew will showcase it. - Stock Titan
Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unveiling a 19% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
New LSE share admission takes Smith & Nephew (NYSE: SNN) to 877,750,024 shares - Stock Titan
Smith & Nephew (NYSE: SNN) will retire $350M bond and delist it in October 2026 - Stock Titan
Oversubscribed bond buyback at Smith+Nephew (NYSE: SNN) leaves many tenders only partly filled - Stock Titan
Smith+Nephew (NYSE: SNN) sets price on $250M cash offer for its 2030 debt, but how much per $1,000 note? - Stock Titan
Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds - Moomoo
Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds - TradingView
Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds - Yahoo Finance
Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds - TradingView
Smith & Nephew stock slips to 52-week low as new USD bond reshapes debt profile - ad-hoc-news.de
Smith & Nephew (SNN) raises $700M in 5.75% debt - Stock Titan
Smith+Nephew (SNN) lines up $700M bond to replace 2030 notes - Stock Titan
Smith & Nephew (NYSE: SNN) lines up new bond to replace 2030 debt - Stock Titan
New 5.75% notes from Smith & Nephew (NYSE: SNN) run to 2036 - Stock Titan
Smith & Nephew stock declines as $250 million bond tender reshapes balance sheet - ad-hoc-news.de
Equity awards vest for Smith & Nephew (NYSE: SNN) strategy chief - Stock Titan
Advanced Micro Devices Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m - Yahoo Finance
Smith & Nephew stock steadies as investors await fresh catalysts - ad-hoc-news.de
Orthopaedics chief at Smith & Nephew (NYSE: SNN) granted new share awards - Stock Titan
Trinity Biotech plcADR Peer Comparison – Compare with Others - valueresearchonline.com
0.11%
1.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):